Effects of Oxazepam, valerian, lavender and placebo on anxiety and sleep quality in patients with coronary artery disease

Phase 2

• Conditions: Coronary Artery Disease.; Coronary Artery Disease

• Registration Number: IRCT2016091429822N1
• Lead Sponsor: Vice-Chancellery for Research and Technology of Birjand University of Medical Sciences

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Last Update Posted: 22 February 2018

Recruitment & Eligibility

• Status: Complete
• Sex: All
• Target Recruitment: 120

Inclusion Criteria

age between 30 to 70 years; willingness to participate in the study; no risk of heart failure (class III and IV) and cardiogenic shock; no use of complementary alternative medicine methods (herbal medicines and other methods) during the two weeks preceding intervention; no use of sleeping drugs, benzodiazepines, and sedative drugs; no addiction; no history of allergy to flowers, plants, valerian and lavender; no history of mental illness; stable vital signs; gaining a score of above 20 on the Spielberger's State and Trait Anxiety Inventory; obtaining a score equal to or over 5 on the Pittsburgh's Sleep Quality Index. Exclusion criteria: No cooperation during the study; sudden changes in the patient's hemodynamic status

Exclusion Criteria

Not provided

Study & Design

• Study Type: interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Sleep quality. Timepoint: before intervention and 3 days after intervention. Method of measurement: Pittsburgh Sleep Quality Index.;State and trait anxiety. Timepoint: before intervention and 3 days after intervention. Method of measurement: Spielberger's State and Trait Anxiety Inventory.